Literature DB >> 8126374

Basement membrane-specific chondroitin sulfate proteoglycan is abnormally associated with the glomerular capillary basement membrane of diabetic rats.

K J McCarthy1, D R Abrahamson, K R Bynum, P L St John, J R Couchman.   

Abstract

We have previously reported the production of monoclonal antibodies (MAb) recognizing the core protein of a basement membrane-specific chondroitin sulfate proteoglycan (BM-CSPG). Using immunohistochemical techniques, we have shown that BM-CSPG is present in almost every basement membrane, one exception being the normal glomerular capillary basement membrane (GBM), where it is absent. In the present study of mature kidneys we examined the distribution of BM-CSPG in streptozocin-induced diabetes mellitus in rats. We found BM-CSPG atypically associated with the GBM of diabetic animals as early as 1 month after induction of diabetes mellitus. Immunoelectron microscopy (IEM) of affected capillary loops showed BM-CSPG present in the subendothelial matrix in areas of GBM thickening and absent in areas where the GBM appears to be of normal thickness. Moreover, the association of BM-CSPG with regions of the pericapillary GBM affects the morphology of the capillary endothelial cells within these areas, directly displacing the cell body from the GBM proper and causing loss of fenestrae. These new data on BM-CSPG distribution reflect abnormal glomerular extracellular matrix protein biosynthesis/turnover in diabetes and suggest that BM-CSPG in the GBM might in turn affect normal capillary structure and/or function.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8126374     DOI: 10.1177/42.4.8126374

Source DB:  PubMed          Journal:  J Histochem Cytochem        ISSN: 0022-1554            Impact factor:   2.479


  13 in total

Review 1.  Autocrine and paracrine mechanisms in the early stages of diabetic nephropathy.

Authors:  G Pugliese; F Pricci; G Romeo; G Leto; L Amadio; C Iacobini; U Di Mario
Journal:  J Endocrinol Invest       Date:  1999-10       Impact factor: 4.256

Review 2.  Extracellular matrix and the kidney.

Authors:  P N Furness
Journal:  J Clin Pathol       Date:  1996-05       Impact factor: 3.411

Review 3.  Diabetic nephropathy and extracellular matrix.

Authors:  S O Kolset; F P Reinholt; T Jenssen
Journal:  J Histochem Cytochem       Date:  2012-10-27       Impact factor: 2.479

Review 4.  Complexities of the glomerular basement membrane.

Authors:  Richard W Naylor; Mychel R P T Morais; Rachel Lennon
Journal:  Nat Rev Nephrol       Date:  2020-08-24       Impact factor: 28.314

5.  A metabolomic study of low estimated GFR in non-proteinuric type 2 diabetes mellitus.

Authors:  D P K Ng; A Salim; Y Liu; L Zou; F G Xu; S Huang; H Leong; C N Ong
Journal:  Diabetologia       Date:  2011-10-25       Impact factor: 10.122

6.  Alterations of glomerular basement membrane charge and structure in diabetic nephropathy.

Authors:  N P Goode; M Shires; D M Crellin; S R Aparicio; A M Davison
Journal:  Diabetologia       Date:  1995-12       Impact factor: 10.122

7.  cDNA cloning of the basement membrane chondroitin sulfate proteoglycan core protein, bamacan: a five domain structure including coiled-coil motifs.

Authors:  R R Wu; J R Couchman
Journal:  J Cell Biol       Date:  1997-01-27       Impact factor: 10.539

8.  Loss of heparan sulfate glycosaminoglycan assembly in podocytes does not lead to proteinuria.

Authors:  Shoujun Chen; Deborah J Wassenhove-McCarthy; Yu Yamaguchi; Lawrence B Holzman; Toin H van Kuppevelt; Guido J Jenniskens; Tessa J Wijnhoven; Ann C Woods; Kevin J McCarthy
Journal:  Kidney Int       Date:  2008-05-14       Impact factor: 10.612

9.  GEC-targeted HO-1 expression reduces proteinuria in glomerular immune injury.

Authors:  Pu Duann; Elias A Lianos
Journal:  Am J Physiol Renal Physiol       Date:  2009-07-08

10.  Reduced sulfation of chondroitin sulfate but not heparan sulfate in kidneys of diabetic db/db mice.

Authors:  Trine M Reine; Frøy Grøndahl; Trond G Jenssen; Elin Hadler-Olsen; Kristian Prydz; Svein O Kolset
Journal:  J Histochem Cytochem       Date:  2013-06-11       Impact factor: 2.479

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.